Development and Application of a Machine Learning Approach to Assess Short-term Mortality Risk Among Patients With Cancer Starting Chemotherapy
Policy, Privacy & Cybersecurity, Digital Care
-
Digital Care
Optimizing health, healthcare delivery, and access through digital technologies. -
Privacy & Cybersecurity
Exploring the ways in which we are protecting the privacy, security, and confidentiality of patient information. -
Policy
Stay up to date with what's happening with healthcare policy and how it affects stakeholders.
Development and Application of a Machine Learning Approach to Assess Short-term Mortality Risk Among Patients With Cancer Starting Chemotherapy
July 30, 2018
Abstract
Importance: Patients with cancer who die soon after starting chemotherapy incur costs of treatment without the benefits. Accurately predicting mortality risk before administering chemotherapy is important, but few patient data–driven tools exist.
Objective: To create and validate a machine learning model that predicts mortality in a general oncology cohort starting new chemotherapy, using only data available before the first day of treatment.
Download (PDF)